eCheminfo Community of Practice InterAction Meeting: Latest Advances in Drug Discovery Design & Plan
Venue: Bryn Mawr College
|Event Date/Time: Oct 16, 2006||End Date/Time: Oct 19, 2006|
|Registration Date: Oct 11, 2006|
|Early Registration Date: Jun 30, 2006|
The eCheminfo Community of Practice InterAction Meeting "Latest Advances in Drug Discovery Design & Planning Methods" will take place 16-19 October 2006, Bryn Mawr, Philadelphia, USA
Program themes include Structure-based Drug Design (SBDD), Screening & Docking, Cheminformatics & Modeling supporting Medicinal Chemistry, Pharmacophores, Metabolomics, Quantum Biochemistry, Knowledge Management, Electronic Lab Notebooks, Critical Path Innovation in Drug Development, Biomarkers, Predictive Toxicology & ADME. In addition to morning presentations and panel discussions, workshops will run each afternoon expanding on the discussion of topics and methods and working through the application of new methods and software to drug discovery & development problems, with bbq, social activity and poster sessions running on campus during the evenings.
The SBDD session will be chaired by Frank Hollinger (Locus Pharmaceuticals) and includes presentations from himself and Erin Duffy (Rib-X), Mike Malams (Wyeth), Debananda Das (NCI), and Max Cummings (J&J PR&D)
The screening session will include Stan Young (NISS), John Irwin (UCSF), Deepak Bandyopadhyay (J&J PR&D), Daryll Reid (Simbiosys), Gregory Warren (GSK), and William Douglas Figg (NCI). We will also host a screening forum to discuss current virtual screening and docking methods and software, results of existing validation and comparison studies, and procedures for community of practice studies to be undertaken.
Bench Scientists & Modellers will discuss their experiences in using Discovery Tools & Modeling in experimental drug discovery and will include Chris Cooper (BMS), James Arnold (Astra-Zeneca), Phil Edwards (Astra-Zeneca), Pete Connolly (J&J PRD), Dimitris Agrafiotis (J&J PRD), and Jim Wikel (Coalesix).
The Pedictive Tox day brings together leading ADME & Tox experts and includes a Keynote from Tudor Oprea and seminars from Navita Mallalieu (Roche), Alex Tropsha (UNC), Curt Breneman (RPI), Karim Kassam (ACD/Labs), Michael Bolger (USC School of Pharmacy), Bob Clark (Tripos), and Gilles Klopman (Multicase).
The program also includes InnovationWell sessions on Drug Development, Metabolomics, Biomarkers, Knowledge Management, and Decision Support which are also available to all registrants to attend.
The preliminary program and schedule can be viewed at:
Reduced rates apply for early registration through 30 June. Academic discounts apply. All registrants are eligible to submit an abstract (ca. 300 words) for the poster sessions.
Please address any questions related to the conference, exhibition or workshop program to Dr. Barry Hardy, eCheminfo Community of Practice Manager, +41 61 851 0170, barry.hardy [at] douglasconnect.com. Registration enquiries should be directed to eCheminfo [at] douglasconnect.com